EFFICACY OF ZOLEDRONIC ACID IN THE PREVENTION OF BONE METASTASES IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER

T. N. Musaev; Мусаев Т. Н.; R. S. Zeinalov; Зейналов Р. С.; A. Kh. Kerimov; Керимов А. Х.; F. A. Guliev; Гулиев Ф. А.; I. N. Musaev; Мусаев И. Н.; A. M. Alizade; Ализаде А. М.; O. V. Adzhalov; Аджалов О. В.

doi:10.17650/1726-9776-2011-7-1-62-65

EFFICACY OF ZOLEDRONIC ACID IN THE PREVENTION OF BONE METASTASES IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER

Authors: Musaev T.N.¹, Zeinalov R.S.¹, Kerimov A.K.¹, Guliev F.A.¹, Musaev I.N.¹, Alizade A.M.¹, Adzhalov O.V.¹
Affiliations:
1. National Cancer Center, Baku, Azerbaijan Republic
Issue: Vol 7, No 1 (2011)
Pages: 62-65
Section: PROSTATE CANCER
Published: 30.03.2011
URL: https://oncourology.abvpress.ru/oncur/article/view/105
DOI: https://doi.org/10.17650/1726-9776-2011-7-1-62-65
ID: 105

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

The analysis of the performed study has established that zoledronic acid is an effective agent in multimodality therapy for locally advanced prostate cancer (PC) and allows long-term stabilization of bone tissue. In addition, there is evidence for the efficacy of zoledronic acid in preventing bone metastases (BM) and increasing the time to the first BM. The currently accumulated experience with zoledronic acid used in PC permits one to consider its use as standard concomitant therapy.